Leavell Investment Management’s Quest Diagnostics DGX Stock Holding History

Leavell Investment Management’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$789K	Sell	3,724 -12	-0.3%	-$2.35K	0.03%	359
2026 Q1	$732K	Sell	3,736 -84	-2%	-$16.3K	0.03%	352
2025 Q4	$663K	Hold	3,820	–	–	0.03%	356
2025 Q3	$728K	Sell	3,820 -10	-0.3%	-$1.77K	0.03%	349
2025 Q2	$688K	Hold	3,830	–	–	0.03%	351
2025 Q1	$648K	Hold	3,830	–	–	0.03%	338
2024 Q4	$578K	Hold	3,830	–	–	0.03%	349
2024 Q3	$595K	Hold	3,830	–	–	0.03%	360
2024 Q2	$524K	Buy	3,830 +222	+6%	+$30.4K	0.03%	351
2024 Q1	$480K	Sell	3,608 -272	-7%	-$35.3K	0.03%	354
2023 Q4	$535K	Sell	3,880 -241	-6%	-$31.7K	0.03%	320
2023 Q3	$502K	Sell	4,121 -100	-2%	-$13.3K	0.04%	330
2023 Q2	$593K	Hold	4,221	–	–	0.04%	309
2023 Q1	$597K	Sell	4,221 -2,185	-34%	-$313K	0.04%	307
2022 Q4	$1M	Hold	6,406	–	–	0.08%	233
2022 Q3	$786K	Sell	6,406 -500	-7%	-$65.8K	0.06%	255
2022 Q2	$918K	Hold	6,906	–	–	0.07%	236
2022 Q1	$945K	Hold	6,906	–	–	0.06%	247
2021 Q4	$1.2M	Sell	6,906 -400	-5%	-$60.9K	0.08%	215
2021 Q3	$1.06M	Hold	7,306	–	–	0.08%	214
2021 Q2	$938K	Hold	7,306	–	–	0.08%	212
2021 Q1	$938K	Hold	7,306	–	–	0.08%	212
2020 Q4	$871K	Sell	7,306 -22	-0.3%	-$2.68K	0.08%	210
2020 Q3	$839K	Hold	7,328	–	–	0.07%	201
2020 Q2	$835K	Hold	7,328	–	–	0.08%	194
2020 Q1	$588K	Hold	7,328	–	–	0.07%	210
2019 Q4	$783K	Hold	7,328	–	–	0.07%	208
2019 Q3	$784K	Sell	7,328 -71	-1%	-$7.29K	0.08%	205
2019 Q2	$753K	Hold	7,399	–	–	0.08%	216
2019 Q1	$665K	Hold	7,399	–	–	0.07%	223
2018 Q4	$616K	Hold	7,399	–	–	0.08%	219
2018 Q3	$798K	Hold	7,399	–	–	0.09%	210
2018 Q2	$813K	Hold	7,399	–	–	0.09%	199
2018 Q1	$742K	Sell	7,399 -492	-6%	-$50.4K	0.09%	220
2017 Q4	$777K	Hold	7,891	–	–	0.09%	206
2017 Q3	$739K	Hold	7,891	–	–	0.09%	202
2017 Q2	$877K	Hold	7,891	–	–	0.11%	179
2017 Q1	$775K	Buy	7,891 +41	+0.5%	+$3.91K	0.1%	181
2016 Q4	$721K	Hold	7,850	–	–	0.1%	188
2016 Q3	$664K	Sell	7,850 -750	-9%	-$63K	0.1%	193
2016 Q2	$700K	Sell	8,600 -47	-0.5%	-$3.58K	0.1%	191
2016 Q1	$618K	Sell	8,647 -753	-8%	-$50.5K	0.09%	201
2015 Q4	$669K	Hold	9,400	–	–	0.1%	188
2015 Q3	$578K	Hold	9,400	–	–	0.09%	200
2015 Q2	$682K	Sell	9,400 -2,000	-18%	-$148K	0.11%	199
2015 Q1	$876K	Hold	11,400	–	–	0.13%	182
2014 Q4	$764K	Hold	11,400	–	–	0.12%	189
2014 Q3	$692K	Hold	11,400	–	–	0.11%	197
2014 Q2	$669K	Hold	11,400	–	–	0.11%	198
2014 Q1	$660K	Sell	11,400 -204	-2%	-$10.9K	0.11%	191
2013 Q4	$621K	Hold	11,604	–	–	0.1%	194
2013 Q3	$717K	Hold	11,604	–	–	0.13%	173
2013 Q2	$704K	Buy	+11,604	New	+$691K	0.13%	170

Other funds holding DGX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

EIG

EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

Leavell Investment Management's DGX Position: Q2 2026 in Review

Leavell Investment Management reduced its Quest Diagnostics (DGX) stake by 0.32% in Q2 2026, selling an estimated $2.35K and leaving 3,724 shares worth $789K. The position accounts for 0.03% of the portfolio, ranked #359.

Leavell Investment Management first reported a position in DGX in Q2 2013 and has held it in 53 quarters since. The position peaked at $1.2M in Q4 2021. 1,100 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

Leavell Investment Management held 3,724 shares of Quest Diagnostics worth $789K as of Q2 2026.
Leavell Investment Management sold 12 Quest Diagnostics shares in Q2 2026, an estimated $2.35K.
Quest Diagnostics made up 0.03% of Leavell Investment Management's portfolio in Q2 2026, its #359 holding.
Leavell Investment Management first reported a position in Quest Diagnostics in Q2 2013 and has held it in 53 quarters since.
Leavell Investment Management's Quest Diagnostics position peaked at $1.2M in Q4 2021.
1,100 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Leavell Investment Management's 13F filing for Q2 2026, filed 21 Jul 2026.